Highlights and Quick Summary
- SG&A Expenses for the quarter ending September 30, 2022 was $450 Thousand (a -0.4% decrease compared to previous quarter)
- Year-over-year quarterly SG&A Expenses decreased by -100.33%
- Annual SG&A Expenses for 2021 was $1.02 Million (a 110.49% increase from previous year)
- Annual SG&A Expenses for 2020 was $484 Thousand (a -64.19% decrease from previous year)
- Annual SG&A Expenses for 2019 was $1.35 Million (a -49.66% decrease from previous year)
- Twelve month SG&A Expenses ending September 30, 2022 was $-133 Million (a -0.16% decrease compared to previous quarter)
- Twelve month trailing SG&A Expenses decreased by -0.69% year-over-year
Trailing SG&A Expenses for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
$-133 Million | $-134 Million | $-134 Million | $-134 Million |
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical SG&A Expenses of Bone Biologics Corp.
Most recent SG&A Expensesof BBLG including historical data for past 10 years.Interactive Chart of SG&A Expenses of Bone Biologics Corp.
Bone Biologics Corp. SG&A Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $0.45 | $0.45 | $0.62 | – |
2021 | $-134.87 | $0.23 | $0.23 | $0.14 | $1.02 |
2020 | – | $0.18 | $0.0 | $0.12 | $0.48 |
2019 | – | – | – | – | $1.35 |
2018 | – | – | – | – | $2.69 |
2017 | – | – | – | – | $3.82 |
2016 | – | – | – | – | $8.81 |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices